GLOMERULONEPHRITIS TREATMENT - NEW APPROA CHES

Before starting treatment of chronic glomerulonephritis it is desirabl e to determine the patient's drug sensitivity in vitro because in the absence of such sensitivity chemotherapy should be preceded by immunom odulation with tactivin or thymalin and 3-5 sessions of plasmapheresis to stimulate drug sensitivity. Further measures include prednisolone or cyclophosphamide intravenously for 3-5 days in a dose 300-500 follo wed by oral administration. Active treatment lasts for 4-8 weeks. Afte r that the patients receive maintenance for 1-2 years.